The use of decision-making aids has helped atrial fibrillation patients to be more informed about their care, according to a study published in the British Medical Journal (BMJ).

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Atrial fibrillation is an example of a heart arrhythmia. Heart failure (also called congestive heart failure, or CHF) is a condition in which the heart is unable to sufficiently pump or fill with ...

On a biological level, ageing is the result of the build-up of cellular and molecular damage in the body over time. The ageing process causes a gradual decline in physical and mental function, a ...

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

Despite these differences, official guidelines in Australia too often ignore the impact of sex and gender on health care. For ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

Fresh research details a method than can detect congestive heart failure (CHF) using smartwatch ECG data with an impressive 90% accuracy in patients.

A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, ...

Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation. One of the core results from AZALEA-TIMI 71 ...